top of page

Revolutionizing Cellular Therapy for Solid Tumors

Harnessing genetic engineering and AI, TriaCyte helps bring your cell therapies to solid tumors, boosting efficacy while reducing development time and cost

Abstract digital illustration of advanced cellular therapy targeting a solid tumor_ glowin

At the frontier of science and technology, we empower cell therapies to tackle hard-to-treat solid tumors.

Homing

Abstract digital illustration symbolizing the homing ability of engineered immune cells. G

Engineered immune cells guided with precision to locate and reach solid tumors

Infiltration

3D render of genetically engineered immune cells attacking a solid tumor in human tissue,

Specialized designs that enable immune cells to penetrate dense tumor environments

AI‑Driven Design

An abstract digital illustration showing artificial intelligence accelerating cellular the

Apply artificial intelligence for smarter CAR and immune cells selection

Our Team

Akram Obiedat, Phd

DSC_5477_edited.jpg
  • LinkedIn

Co-founder and CEO

Akram leads TriaCyte's strategic vision, business development, and translational efforts to advance next-generation cell therapies for solid tumors. He holds a PhD in Immunology and Pharmacology and brings over six years of experience in immunotherapy development.

Nour Atamni

9DB993AA-C2D5-477D-8CC1-FE1A34DE6848.png
  • LinkedIn

Co-founder and CTO

Nour leads TriaCyte's AI-driven computational platform, integrating machine learning and biological insights to engineer next-generation proteins for immune cell therapies. He is a PhD candidate in Computer Science at Ben-Gurion University, specializing in artificial intelligence.

Cyrille Cohen, PhD

×”×™×Ø×™×œ כהן-34-ed_edited.jpg
  • LinkedIn

Scientific co-founder

Cyrille guides TriaCyte's scientific strategy, bringing extensive expertise in cancer immunotherapy and engineered cell therapies. He serves as Rector of Bar-Ilan University and leads the Tumor Immunology & Immunotherapy Laboratory.

Scientific Advisory Board

Marcela Maus Innovator in Healthcare.JPG

Professor of Medicine 

Director, Cancer Institute Program in Cellular Immunotherapy

Harvard Medical School

Mass General Brigham Cancer Institute

  • LinkedIn
  • Website icon
Picture1.jpg

Professor of Medicine

Scientific Co-Director, Cell Therapy and Transplant Program

​Hospital of the University of Pennsylvania

  • LinkedIn
  • Website icon
bottom of page